As smaller hospitals get overwhelmed with covid-10 patients in need of ventilators, there is an easy way to modify commonly found bi-level positive air pressure (BIPAP) machines to act as ventilators.
Dr. Keith Robinson is available to explain how Syneos Health is providing free training materials for health professionals to learn how to convert BiPAP machines into ventilators. The critical shortage of ventilators is causing physicians to make difficult decision about which patients will receive ventilator treatment.
BiPAP machines are in ready supply in most hospitals and to save as many lives as possible during this pandemic, the FDA has stated that it will not object to modifications such as the use of a BiPAP machine as a ventilator, and the American Hospital Association is supporting the training.
Dr. Robinson can demonstrate how commonly used bi-level positive air pressure (BiPAP) machines can act as ventilators in some COVID-19 patients with simple changes of BiPAP settings, including the use of intubation instead of a regular oxygen mask.
He’s currently working in the ICU at a hospital in Florida and is also training teams there on using the BIPAP machines as ventilators.
A free website has been set up for medical professionals to learn how to adapt their existing BiPAP machines to bridge the gap until more mechanical ventilators come on the market: www.COVID-BiPAPinfo.com and you can use the b-roll in the video for your story.
About Dr. Keith Robinson —
Keith Robinson is Medical Director with the Medical Management & Scientific Services group of Syneos Health. Keith is a board certified Pulmonary Medicine and Critical Care Medicine physician with over 14 years of clinical experience. Before Syneos, Keith worked as an Intensivist and Pulmonary Medicine Consultant with Pulmonary Physicians of South Florida, LLC, serving as Medical Director of Fusion Health Pulmonary Rehabilitation & Wellness for 7 years. His professional activities include 10 years of clinical research, as a principle investigator, in pneumonia, asthma, COPD, and pulmonary hypertension trials. In addition, Keith has spent 10 years as a consultant and advisor to Astra Zeneca, Mylan, Theravance, Sunovion, Actelion, and CAIRE Industries.
